AuraSense raises $13.6 million in series C

AuraSense Therapeutics LLC (Skokie, Ill.) raised $13.6 million in a series C round. The company is developing therapies based on its Spherical Nucleic Acid constructs, which are nanoscale particles that consist of a spherical arrangement of densely packed and radially oriented nucleic acids. AuraSense said its programs are in preclinical testing and that the technology could be used for cancer, infectious disease and skin conditions. ...